Model 802 Gillian QA Phantom lo res

May 11, 2010 - Hybrid scanning systems are increasingly being used to improve tumor identification, treatment delivery and monitor treatment effectiveness.

Proper alignment of fused images is an ongoing concern, particularly with hybrid modalities, such as single photon emission computed tomography/computed tomography (SPECT/CT), positron emission tomography/computed tomography (PET/CT) and computed tomography/magnetic resonance imaging (CT/MRI).

The Model 802 Gillian QA Phantom recently released by CIRS Inc. is designed for evaluating image distortion and alignment in these hybrid scanning systems.

Images produced with the phantom can show if there is any mismatch in the fused images. The simple geometry allows for quick visual interpretation and independent assessment of equipment function.

This product is manufactured under license from King’s College Hospital NHS Foundation Trust.

For more information: www.cirsinc.com


Related Content

News | Radiology Imaging

Aug. 13, 2026 — Epic's new Care Everywhere Diagnostic Image Exchange allows health systems using Epic to share ...

Time August 21, 2026
arrow
News | Cardiac Imaging

Aug. 20, 2026 – The novel, radiopaque, polymer-based embolic coil from Embolization, Inc. has now surpassed 125 implants ...

Time August 20, 2026
arrow
News | Breast Imaging

Aug. 13, 2026 – Perimeter Medical Imaging AI recently announced that Intermountain Health, the largest nonprofit health ...

Time August 14, 2026
arrow
News | Lung Imaging

Aug. 11, 2026 — Noah Medical has launched the Galaxy II software, the next evolution of its robotic-assisted ...

Time August 10, 2026
arrow
News | Radiology Business

Aug. 4, 2026 — Canon Medical Systems USA (CMSU) has appointed Tsuneo "Neo" Imai as president and chief executive officer ...

Time August 10, 2026
arrow
News | Radiology Imaging

Aug. 4, 2026 — A new study from the Harvey L. Neiman Health Policy Institute found that the time between an imaging scan ...

Time August 06, 2026
arrow
News | Contrast Agents

Aug. 5, 2026 — Bracco Group is bringing a newly authorized macrocyclic gadolinium-based contrast agent (GBCA) for ...

Time August 05, 2026
arrow
News | Neuro Imaging

July 9, 2026 — Viz.ai has announced a collaboration with Cortechs.ai to integrate Cortechs.ai's NeuroQuant and ...

Time July 10, 2026
arrow
News | Radiation Oncology

July 8, 2026 — GE HealthCare and Mayo Clinic have announced the MI-BET (Molecular Imaging Biomarker-Based End of Therapy ...

Time July 09, 2026
arrow
News | MRI Breast

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which ...

Time July 02, 2026
arrow
Subscribe Now